Table 2.
Variable | Benign (n= 79) | Malignant (n= 35) | P-value | Sens. | Spec. | PPV | NPV | LR+ | LR− |
---|---|---|---|---|---|---|---|---|---|
Age mean (SD) | 59.1 (13.2) | 65 (12.4) | 0.02 | N/A | N/A | N/A | N/A | N/A | N/A |
Female | 68% | 57% | 0.29 | 57% | 32% | 27% | 63% | 0.83 | 1.34 |
Symptoms | 83% | 94.3% | 0.14 | 94% | 25% | 36% | 91% | 1.25 | 0.24 |
High CA19-9 (>35 mg/dl) | 22% | 67% | 0.001 | 67% | 78% | 64% | 80% | 3.04 | 0.42 |
Head of the pancreas | 29% | 71% | 0.001 | 71% | 71% | 52% | 85% | 2.45 | 0.41 |
Size cm Mean (SD) | 4.1 (2.9) | 5.6 (3.6) | 0.04 | N/A | N/A | N/A | N/A | N/A | N/A |
Symptoms & high CA19-9 | 64% | 84% | 0.0082 | 64% | 84% | 82% | 61% | 4 | 0.43 |
Symptoms & head of pancreas | 56.9% | 83% | 0.03 | 57% | 83% | 49% | 62% | 3.35 | 0.52 |
High CA19-9 & head of pancreas | 28% | 70% | <0.001 | 28% | 70% | 45% | 83% | 4.2 | 1.03 |
LR+, positive likelihood ratio; LR−, negative likelihood ratio; NPV, negative predictive value; PPV, positive predictive value.